![Emily Faucette](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emily Faucette
Investor Relations Kontakt bei TALIS BIOMEDICAL CORPORATION
Aktive Positionen von Emily Faucette
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TALIS BIOMEDICAL CORPORATION | Investor Relations Kontakt | 01.01.2021 | - |
Public Communications Contact | 01.01.2021 | - |
Karriereverlauf von Emily Faucette
Ehemalige bekannte Positionen von Emily Faucette
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.02.2020 | 01.07.2020 |
GENOMIC HEALTH, INC. | Investor Relations Kontakt | - | - |
Public Communications Contact | - | - |
Ausbildung von Emily Faucette
American University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Investor Relations Contact | 3 |
Public Communications Contact | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TALIS BIOMEDICAL CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Genomic Health, Inc.
![]() Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Portola Pharmaceuticals LLC
![]() Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Emily Faucette
- Erfahrung